Tender For corrigendum : supply of medicines - insulin glulisine injection cartridge 100 iu or ml and 03 ml , inj insulin aspart 100 u or ml and 3 ml pen , soluble insulin injection 100 iu or ml of human actrapid 3 ml pen , insulin aspart 50 percent plus protamin crystallised aspart 50 percent 100 iu or ml and 3ml pen , insulin isophane or nph 70 percent and human insulin or soluble insulin 30 percent of mixtard 30 or 70 insulin inj and 100 iu or ml and 3 ml pen , insulin lispro biphasic 50 percent of 50 percent insulin lispro and 50 percent insuline lispro protamine suspension of 100iu or ml and 3ml cartridge , insulin premixed biphasic human of 50 percent human neutral 50 percent human isophane insulin of 10 ml inj
Tender For bid to ras bid to ras supply of dglp qe sep pvms aon 5-- enema sodium phosphate ml 6 percent sod acid phosphate 16 percent pack of 100ml , bisacodyl tab 5 mg perpn tab , norfloxacin 400mg plus tinidazole 600mg tab , oral rehydration power sachet of 20 point 5g , secnidazole tab 1 gm , pancreatic enzyme casules with a lipase content of 10000 to 20000 units , ofloxacin 200mg plus ornidazole 500mg tab , tab loperamide 2mg , danazol 100 mg cap , clotrimazole vaginal pessary 100mg , povidone iodine 5 percent pessary , inj magnesium sulphate 50 percent w per v , acarbose 25 mg tab , voglibose 0 point 2 mg tab , human insulin analogue rapid acting inj 100 iu per ml recombinant dna origin 300 iu disposable pen with 5 needles per pen , insulin highly purified isoplhane inj human nph 40iu per ml 10 ml vial , tab empagliflozin 10mg , tab empagliflozin 25mg , carbimazole tab 5 mg , thyroxine sodium 0 point 025 mg tab , glycopyrrolate 0 point 2 m g per ml 1 ml inj , succinylchloline chloride inj50mg per ml vial of 2 ml , flavoxate 200mg tab , erythropoeitin human recombinant 4000 iu inj , tacrolimus 1 mg tab , tacrolimus 0 point 5mg cap , tab sevelamer 400 mg tab , etophyllin bp 84 point 7mg and theophyllin ip 25 point 3mg per ml ampoule of 2mlinj , tab risperidone 2 mg , tab risperidone 4 mg , tab sertraline 50mg , quetiapine 50mg tab , autohaler salmetrol 50mcg plus fluticasone 500mcg in 120 doses , formetrol 20mcg plus budesonide 0 point 5mg respules , levosalbutamol aerosol pack of 200 md each metered dose supplies 50 mcg , formoterol 12 mcg and fluticasone 250 mcg dry powder , bromhexine syp 5 ml containing 4 mg of bromhexine hcl bott of 120ml , dextrose monohydrate for oral use pkt of 100gm , dextrose 50 percent inj , dextrose inj 25 percent in amp of 25 ml , potassium chloride liquid 20 percent bott of 200ml , sodium bicarbonate 7 point 5 percent amp of 10 ml , inj meropenam 1gm , tab alfuzocin 10 mg , cream anti phlebitis tube of 15g per 20g //bid details2 / 38
Tender For corrigendum : supply of sch i (supply of injections & sera vaccines) - sch i (supply of injections & sera vaccines), inj. b complex for prophylactic use vit. c 150mg vit. b 12 2500 mcg folic acid 0.7 mg niacinamide 12 mg, inj. b complex for therapeutic use each ml contain vit a 1000 iu cholecalciferol 100 iu alphatochopherol acetate 0.5 mg. thiamine 5 mg. pyridoxine 0.5 mg. nicotinamide 10 mg. ascorbic acid 50mg. d-panthenol 2.5 mg., inj. calcium gluconate 10% iv use., inj. desferroxamine 500 mg, inj. digoxin 0.5 mg iv use, inj. diltiazem 5 mg/ml, inj. fluconazole 200 mg. in plastic bottle, inj. fluorescein sodium (20%), inj. hydralazine 20 mg. iv, inj. hyaluronidase 1500 iu, inj. insulin plain (purified human) 40 units/ml sc/iv use (insulin plain and insulin nph/ lente should be of the same manufacturer and their rate will be considered as a unit.), inj.insulin nph/isophane40 iu (highly purified bovine porcine isophane insulin susp 40 i.u./ml nph insulin (or neutral protamine hagedorn)., inj. isoxsuprine hcl 10 mg/ml., intravenous injection of n (2)-l alanyl-l glutamine 20%, solution 50 ml, iv lipid 20% for neo-natal use., inj.lorazepam 2 mg/ml im/iv use., inj. l-ornithine l-aspartate 5 gm, inj. n-butyl cyanoacrylate 0.5 gm., inj. methylene blue 10 mg/ml, inj. metoprolol 5mg, nitroglycerine lingual spray in ready to use formulation. each spray should deliver 0.35 to 0.4 mg/spray 60-70 lit/spray., inj. phenobarbitone sodium 200 mg iv use, inj. protamine sulphate 1% iv use, inj. somatostatin 3 mg /vial, sterile & pyrogen free water for injection i.p 5ml, inj.sterile & pyrogen free water for injections i. p. 10 ml, inj. thiamine 100 mg/ml, inj. tricort triamcinolone sodium 10 mg, inj. tuberculine p. p. d. 5 t. u./0.1 ml intradermal use., inj. vit. k 10 mg/ml (aqueous) i. m./i. v., inj. valethamate bromide 8 mg, inj. benzathine penicillin 6 lacs unit for im use, inj. benzathine penicillin 12 lacs unit im use, inj. benzyl penicillin/ penicillin g/ crystalline penicillin salt 1000000 units/bulbs i. m./i. v., inj. ofloxacin 200 mg, inj. streptomycin sulphate 0.75 gm, inj. anti d 300 microgram/dose polyclonal/monoclonal, inj. diptheria antitoxin 10000 iu, inj. hepatitis b vaccine recombinant dna technology 20 mcg/ml, inj. hib vaccine 10 mcg. haemophilus influenza type b. polysacchride conjugate vaccine. [powder to be reconstituted with 0.5 ml diluent (saline)]., inj. human rabies immunoglobulin 150 i.u./ml, inj meningococcal conjugate vaccine single dose vial containing (a, c, y & w 135) polysaccharide conjugated to diptheria toxoid protein carrier., inj. mmr vaccine (measles, mumps & rubella) single dose im or sc., inj. pneumovax (pneumococcal 23 valent vaccine), inj. polyvalent antisnake venom serum- should contain equivalent of 10 ml of purified globulins 1 ml of reconstituted serum to neutralizes 0.5 mg to 0.6 mg of dried cobra venom, 0.45 mg of dried common krait venom, 0.6 mg. of dried russells viper venom, 0.45 mg of dried saw scaled viper venom, liquid or powder form will be accepted, inj. rabies human monoclonal antibody (rdna) 40 iu/ml., inj. tetanus vaccine purified toxoid adsorbed i. p. 5 lf./0.5ml, inj. tetanus immunoglobulin (human) 250 i. u. im / intrathecal use., inj. tetanus immunoglobulin (human) 500 i. u. im / intrathecal use., inj. lignocaine 10% spray, inj. propofol 1% mct/lct fat emulsion with sodium oleate 50 ml, inj. ropivacaine hcl 0.5%, inj. 2% hydroxypropyl methyl cellulose preservative free sterile for intraocular use during cataract surgery in sterile prefilled syringe & with sterile cannula., intracameral injection lignocaine hydrochloride 1%, inj. perfluoro-n-octane liquid for intraocular use sterile, inj. pilocarpine (0.5%) nitrate/hcl sterile opthalmic solution for injection., inj. silicon oil for (polydimethyl siloxane for intraocular use) sterile viscosity 1500 mm2/s cst, inj. sodium hyaluronate 1.4%, inj. sodium hyaluronate 1.8%, inj. continuous ambulatory peritoneal d
Tender For supply of fusidic acid 2 percent and clotrimazole 1 percent and clobetasol 0. 05 percent w or w oint, tube of 10gm , gabapentin 300mg and methylcobalamin 1500 mcg tab , gamma benzene hexachloride 1 percent w or v, cetrimide 0. 1 percent w or v in alcoholic solution , gatifloxacin 0. 3 percent and prednisolone 1 percent , 5 ml eye drops , gauze surgical, open wove, unmedicated, 60 cm x 18 metres packet , gentamycin eye or ear drop, bott of 5 ml , glipizide 5 mg tab , glutamine sachet of 7 gm , glutathione 250mg tab , glycerine ip, bottle of 100 ml , glycerine suppository , griseofulvin 250mg tab , halobetasol 0. 05 percent oint, tube of 20 gm , halobetasol 0. 05 percent and salicylic acid 3 percent w or w cream, tube of 15 gm , human insulin analogue glargine inj 100 iu or ml recombinant dna origin 300 iu disposable pen with 5 needles per pen , 3 ml pfp , inj insulin aspart 100iu or ml pen human insulin analogue rapid acting inj, 100 iu or ml recombinant dna origin 300 iu disposable pen with 5 needles per pen ) /bid number: gem/2025/b/7054027 * /dated: 19-01-2026 & & / bid document1 / 19